Phase 2 clinical research published in 2023 documented metabolic effects that exceeded those reported for any prior incretin agonist
Targeting ferroptosis for cancer therapy: exploring novel strategies from its mechanisms and role in cancers
Can I choose my GLP-1 preference during the PlexusDx intake
Dr Dhirendra Singhania, a leading cardiologist, pointed to steroids, hormone therapies, and poor sleep as major heart risk factors, even among seemingly fit individuals
Resources AACR 2026 Poster See screening performance data across suspension, adherent, and 3D cancer cell models Assays and Tools to Monitor Biology in 3D Cell Cultures View our practical guide to transitioning cell health assays from 2D to 3D
It also frames medication as an addition to continued lifestyle support rather than a replacement for it